Skip to main content
logo
Strides Pharma Science Limited (NSE:STAR)
India flag India · Delayed Price · Currency is INR
857.65
-8.10 (-0.94%)
At close: Feb 13, 2026

Strides Pharma Science Revenue

Strides Pharma Science had revenue of 11.95B INR in the quarter ending December 31, 2025, with 3.55% growth. This brings the company's revenue in the last twelve months to 47.26B, up 3.19% year-over-year. In the fiscal year ending March 31, 2025, Strides Pharma Science had annual revenue of 45.65B with 17.36% growth.

Revenue (ttm)
47.26B
Revenue Growth
+3.19%
P/S Ratio
1.67
Revenue / Employee
14.32M
Employees
3,301
Market Cap
79.05B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202545.65B6.75B17.36%
Mar 31, 202438.90B2.02B5.47%
Mar 31, 202336.88B6.18B20.13%
Mar 31, 202230.70B-2.46B-7.41%
Mar 31, 202133.16B5.64B20.49%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Alembic Pharmaceuticals72.67B
NATCO Pharma45.63B
Akums Drugs and Pharmaceuticals43.19B
Eris Lifesciences30.59B
Alivus Life Sciences25.12B
Aarti Pharmalabs18.01B
Innova Captab14.97B
Cohance Lifesciences12.11B
Revenue Rankings

Strides Pharma Science News

More News